| 摘要 |
<p>The present invention provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula I as selective 5-HT 2C receptor agonists for the treatment of 5-HT 2C associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety:
where:
R 6 is -S-L-R 15
and other substituents are as defined in the specification.</p> |
| 申请人 |
ELI LILLY AND COMPANY |
发明人 |
ALLEN, JOHN, GORDON;TIDWELL, MICHAEL, WADE;VICTOR, FRANTZ;WILLIAMS, ANDREW CAERWYN;ZHANG, DEYI;BOYD, STEVEN, ARMEN;CONWAY, RICHARD, GERARD;DEO, ARUNDHATI, S;LEE, WAI-MAN;SIEDEM, CHRISTOPHER, STEPHEN;SINGH, AJAY;BRINER, KARIN;COHEN, MICHAEL, PHILIP;GALKA, CHRISTOPHER, STANLEY;HELLMAN, SARAH, LYNNE;MARTINEZ-GRAU, MARIA ANGELES;REINHARD, MATTHEW, ROBERT;RODRIGUEZ, MICHAEL, JOHN;ROTHHAAR, ROGER, RYAN |
